Delivery Order SPE2DB24D1104-SPE2DB25FYER7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,705.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The award, issued on July 24, 2025, with completion targeted for July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $33,624.70 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of August 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters, where it maintains significant pharmaceutical distribution operations supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $15,801.10 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this...
- The Defense Logistics Agency awarded a $15,808.62 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. The contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and carries firm fixed pricing under a non-set-aside competitive award. Performance of the contract is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $33,106.50 to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with an ultimate completion date of July 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a routine pharmaceutical procurement supporting federal medical supply needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count supply) on July 21, 2025, with completion targeted for July 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects standard pharmaceutical procurement through the federal medical supply chain. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $10,308.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed price, non-set-aside contract with a completion date of July 22, 2025, and performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a relatively small transaction within the company's extensive federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $15,235.54 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. This firm fixed-price delivery order, awarded on July 28, 2025, with a completion date of July 29, 2025, represents a non-competitive, non-set-aside procurement executed against an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $17,006.14 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed price contract. The award was issued on July 30, 2025, with a completion date of July 31, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $50,458.16 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a brand-name anticoagulant medication. This firm fixed-price delivery order, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYER7Delivery Order
The Defense Logistics Agency awarded a $50,623.08 delivery order to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, a widely used anticoagulant medication. The contract was competitively awarded with no set-aside designation under a firm fixed-price structure, with an ultimate completion date of August 18, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this delivery order. This award represents a task order executed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio and demonstrated capability in fulfilling competitive pharmaceutical procurement requirements positioned the company to deliver this critical medication for military and federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.6k | 8/15/25 |